EU AI Act Article 14: human oversight of high-risk AI systems

Article 14 is one of the most consequential design requirements in the EU AI Act for product teams. It mandates that high-risk AI systems be designed to allow natural persons to effectively oversee the system during its operation. This is not a policy question for your legal team alone; it is an engineering requirement that must be built into your product architecture. For CTOs at startups whose AI systems influence consequential decisions about people, Article 14 defines what your UI, alerting mechanisms, and override workflows must be capable of before your product can legally operate in the EU market.

What the EU AI Act requires

Article 14(1) requires that high-risk AI systems be designed and developed in a way that allows the natural persons to whom oversight is assigned to effectively oversee the system's operation. Article 14(3) specifies four concrete capabilities that high-risk AI systems must support: the ability for oversight persons to fully understand the system's capacities and limitations; the ability to remain aware of automation bias (the tendency to over-rely on AI output); the ability to correctly interpret the system's output; and the ability to decide not to use the system, or to override or reverse its output in any particular case. Article 14(4) adds that for systems that operate autonomously, providers must ensure oversight persons can intervene or interrupt operation via a stop button or equivalent procedure. Article 14(5) places a proportionality requirement on oversight, allowing a risk-based approach that considers the context and degree of automation involved.

What this means for your business

For a startup building an AI-assisted hiring screening tool, Article 14 means your interface must not present AI recommendations as final decisions. It must surface confidence indicators, flag low-confidence outputs, and provide a clear mechanism for the hiring manager to record that they reviewed and either accepted or overrode the AI recommendation. For a medical AI startup, this may mean mandatory clinician sign-off workflows before the AI output is acted upon. These are product requirements, not disclaimers. Regulators will assess whether the human oversight mechanism is genuinely effective or whether it is a cosmetic feature designed to shift liability. The compliance deadline for Annex III high-risk systems is December 2, 2027.

Steps to get compliant

1. Map every point in your product's user journey where the AI system produces an output that influences a consequential decision, and identify which of those points currently lack human review steps.
2. Design explicit human oversight interfaces for those decision points, including confidence or uncertainty indicators, explanation summaries, and override controls with audit trail logging.
3. Review your instructions for use under Article 13 to ensure the oversight role is clearly described to deployers, including the qualifications or training required for the oversight function.
4. Test the oversight mechanism with real users to verify it mitigates automation bias in practice, documenting the test methodology and findings in your Article 9 risk management records.

Free EU AI Act risk assessment

Not sure where your AI system stands? The free ActComply risk screener classifies your system in under 5 minutes. No sign-up required.